α-Ethyltryptamine: A Ratiocinatory Review of a Forgotten Antidepressant

Area of Science:

• Neuroscience
• Psychopharmacology
• Medicinal Chemistry

Background:

• α-Ethyltryptamine (AET) is a centrally acting agent with a long history, previously used as an antidepressant.
• AET was withdrawn and scheduled due to concerns about abuse liability and toxicity.
• Recent interest in serotonergic psychedelic agents for neuropsychiatric disorders prompts a re-evaluation of AET.

Purpose of the Study:

• To critically review the history of α-Ethyltryptamine (AET).
• To assess whether AET exhibits characteristics of a serotonergic psychedelic agent.
• To determine if AET or its analogs merit further investigation as potential therapeutics.

Main Methods:

• Historical literature review of AET.
• Analysis of AET's pharmacological profile and historical clinical use.
• Comparative assessment with current psychedelic-assisted therapies.

Main Results:

• AET possesses properties consistent with antidepressant activity.
• The historical withdrawal of AET may have been premature given current therapeutic trends.
• AET's pharmacological profile suggests potential, warranting further study.

Conclusions:

• AET may have been an antidepressant agent ahead of its time.
• Further investigation into AET derivatives, especially optical isomers, is justified.
• AET analogs could represent novel therapeutic avenues for neuropsychiatric conditions.